Cargando…

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis

INTRODUCTION: The 21-gene assay provides prognostication for estrogen receptor positive, human epidermal growth factor receptor-2 negative (ER+/HER2-) early female breast cancer patients. This signature has not been validated in male breast cancer (MBC). METHODS: A systematic review and meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Matthew G., Davey, Ciara M., Bouz, Luis, Kerin, Eoin, McFeetors, Carson, Lowery, Aoife J., Kerin, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079225/ https://www.ncbi.nlm.nih.gov/pubmed/35512428 http://dx.doi.org/10.1016/j.breast.2022.04.009

Ejemplares similares

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
por: Bouz Mkabaah, Luis, et al.
Publicado: (2023)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials
por: Davey, Matthew G., et al.
Publicado: (2022)

Radiomic Detection of Malignancy within Thyroid Nodules Using Ultrasonography—A Systematic Review and Meta-Analysis
por: Cleere, Eoin F., et al.
Publicado: (2022)

Molecular profiling in contemporary breast cancer management
por: Davey, Matthew G, et al.
Publicado: (2023)

Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer
por: Davey, Matthew G., et al.
Publicado: (2023)

Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2023)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
por: Davey, Matthew G, et al.
Publicado: (2022)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Comparing surgical outcomes of approaches to adrenalectomy — a systematic review and network meta-analysis of randomised clinical trials
por: Davey, Matthew G., et al.
Publicado: (2023)

Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
por: O’Halloran, Niamh, et al.
Publicado: (2017)

Breast cancer recurrence: factors impacting occurrence and survival
por: Courtney, Donald, et al.
Publicado: (2022)

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)

Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
por: O'Connor, Dómhnall J., et al.
Publicado: (2021)

Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration
por: O’Halloran, Niamh, et al.
Publicado: (2019)

Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer
por: Davoren, Pamela A, et al.
Publicado: (2008)

The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer
por: Richard, Vinitha, et al.
Publicado: (2022)

The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2008)

Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
por: Abbas Syed, Raza, et al.
Publicado: (2023)

General data protection regulations (2018) and clinical research: perspectives of patients and doctors in an Irish university teaching hospital
por: Davey, Matthew G., et al.
Publicado: (2021)

Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer—A State-of-the-Art Review
por: Cronin, Michael, et al.
Publicado: (2023)

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review
por: Lunardi, Mattia, et al.
Publicado: (2022)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blhm4bjiplk6c9ht0vkvuot5um